Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. (Q33373912)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. |
scientific article |
Statements
1 reference
Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13. (English)
1 reference
Marie Scully
1 reference
Hannah Cohen
1 reference
Jamie Cavenagh
1 reference
Sylvia Benjamin
1 reference
Richard Starke
1 reference
Sally Killick
1 reference
Ian Mackie
1 reference
Samuel J Machin
1 reference
1 February 2007
1 reference
1 reference
136
1 reference
451-461
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference